Pilot study comparing the diffusion of two formulations of botulinum toxin type A in patients with forehead hyperhidrosis

Dermatologic Surgery

Volumn 33, Issue SUPPL. 1, 2007, Pages

  Trindade De Almeida, Ada R ^a,b   Marques, Elisa ^a   De Almeida, Janete ^a   Cunha, Thais ^a   Boraso, Rosana ^a  

^a HOSPITAL DO SERVIDOR PÚBLICO ESTADUAL DE SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ADULT; ANHIDROSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER PROGRAM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DIFFUSION; DRUG EFFECT; DRUG FORMULATION; FEMALE; FOREHEAD; HUMAN; HYPERHIDROSIS; MALE; MUSCLE CONTRACTION; MUSCLE RELAXATION; PHOTOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; ADULT; BOTULINUM TOXIN TYPE A; DIFFUSION; FEMALE; FOREHEAD; HUMANS; HYPERHIDROSIS; INJECTIONS; MALE; MIDDLE AGED; MUSCLE CONTRACTION; NEUROMUSCULAR AGENTS; PILOT PROJECTS;

EID: 33845999297     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2006.32330.x     Document Type: Article

References (15)

1. Smuts JA, de Boulle K, van Coller R, Barnard PW. An electrophysiological study to demonstrate in vivo differences between two types of botulinum toxin type A (BOTOX® and DYSPORT®). Poster presented at the 8th International Congress of Parkinson's Disease and Movement Disorder; 2004 Jun 13-17; Rome, Italy.
2. Lowe PL, Patnaik R, Lowe NJ. A comparison of two botulinum type A toxin preparations for the treatment of glabellar lines: double-blind, randomized, pilot study. Dermatol Surg 2005;31:1651-4.
3. Aoki R, Francis J, Reynolds H, Leumer D. Comparison of the therapeutic windows of different botulinum neurotoxin preparations in an animal model. Neurology 2003;60:(5 Suppl 1): A212-3.
4. Aoki KR. A comparison of the safety margins of botulinum neurotoxin serotypes A, B, and F in mice. Toxicon 2001;39: 1815-2.
5. Borodic GE, Ferrante R, Pearce LB, Smith K. Histologic assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum A toxin injections. Mov Disord 1994; 9:31-9.
6. Tugnoli V, Eleopra R, Montecucco C, De Grandis D. The therapeutic use of botulinum toxin. Expert Opin Invest Drugs 1997;6:1383-94.
7. Hsu TS, Dover JS, Arndt KA. Effect of volume and concentration on the diffusion of botulinum exotoxin A. Arch Dermatol 2004;140:1351-4.
8. Eleopra R, Tugnoli V, Caniatti L, De Grandis D. Botulinum toxin treatment in the facial muscles of humans: evidence of an action in untreated near muscles by peripheral local diffusion. Neurology 1996;46:1158-60.
9. Nüssgens Z, Roggenkämper P. Comparison of two botulinum-toxin preparations in the treatment of essential blepharospasm. Graefes Arch Clin Exp Ophthalmol 1997;235:197-9.
10. Lew H, Yun YS, Lee SY, Kim SJ. Effect of botulinum toxin A on facial wrinkle lines in Koreans. Ophthalmologica 2002; 216:50-4.
11. Odergren T, Hjaltason H, Kaakkola S, et al. A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia. J Neurol Neurosurg Psychiatry 1998;64:6-12.
12. Carruthers A, Carruthers J. Botulinum toxin type A: history and current cosmetic use in the upper face. Semin Cutan Med Surg 2001;20:71-84.
13. Hexsel D, Dal T, Dini F, et al. Diffusion, dispersion, or action halos of botulinum toxins? A pilot study comparing two commercial preparations of type A botulinum toxins [Abstract 153-06]. J Am Acad Dermatol 2005;52:(3 Suppl 2):AB2.
14. de Almeida AR, Chisaki C. Craniofacial hyperhidrosis. In: de Almeida AR, Hexsel D editors. Hyperhidrosis and botulinum toxin. São Paulo, 2004: p. 173-8.
15. Flynn TC, Clark RE. Botulinum toxin type B (Myobloc) versus botulinum toxin type A (Botox) frontalis study: rate of onset and radius of diffusion. Dermatol Surg 2003;29:519-22.